In contrast, FUNDC1 could also resist the occurrence and progression of some cancers (HCC,122 ovarian cancer, lung cancer128), which might be related to the close connection between FUNDC1 and metabolic reprogramming and cellular plasticity in cancer. This evidence concerns the gene FUNDC1 and hepatocellular carcinoma.